| PERIOD ENDING | 31-Mar-04 | | Total Revenue | 83,455 | | Cost of Revenue | 57,865 | | | Gross Profit | 25,590 | | | Operating Expenses | | Research Development |
-
| | Selling General and Administrative | 7,060 | | Non Recurring |
-
| | Others |
-
| | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | 18,530 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (490) | | Earnings Before Interest And Taxes | 18,040 | | Interest Expense | 2,132 | | Income Before Tax | 15,908 | | Income Tax Expense | 5,377 | | Minority Interest |
-
| | | | Net Income From Continuing Ops | 10,531 | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | 10,531 | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | $10,531 |
|
1.52% Nasdaq 0.00%
Income Statement
